Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 218.78M P/E - EPS this Y 38.30% Ern Qtrly Grth -
Income -33.97M Forward P/E -2.89 EPS next Y 19.50% 50D Avg Chg -1.00%
Sales - PEG 0.85 EPS past 5Y - 200D Avg Chg -24.00%
Dividend N/A Price/Book 3.55 EPS next 5Y -9.40% 52W High Chg -67.00%
Recommedations 1.60 Quick Ratio 6.10 Shares Outstanding 26.30M 52W Low Chg 18.00%
Insider Own 47.94% ROA -49.79% Shares Float 13.56M Beta 0.92
Inst Own 13.21% ROE -136.52% Shares Shorted/Prior 1.72M/1.86M Price 4.30
Gross Margin - Profit Margin - Avg. Volume 57,675 Target Price 8.86
Oper. Margin - Earnings Date Mar 20 Volume 27,639 Change -0.46%
About Rani Therapeutics Holdings, Inc

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.

Rani Therapeutics Holdings, Inc News
03/21/24 Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2023 Earnings Call Transcript
03/21/24 RANI: 2023 Results
03/21/24 Q4 2023 Rani Therapeutics Holdings Inc Earnings Call
03/20/24 Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update
03/15/24 Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
03/12/24 Individual investors own 40% of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) shares but private companies control 47% of the company
02/20/24 RANI: INITIATION – Realizing Oral Administration of Biologics
02/05/24 Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111)
12/14/23 Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist
12/07/23 What Makes Rani Therapeutics Holdings, Inc. (RANI) a New Buy Stock
11/24/23 Jean-Luc Butel Buys Handful Of Shares In Rani Therapeutics Holdings
11/24/23 Pleasing Signs As A Number Of Insiders Buy Rani Therapeutics Holdings Stock
11/08/23 Rani Therapeutics Holdings Inc (RANI) Reports Q3 2023 Financial Results and Corporate Developments
11/08/23 Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update
03:05 PM Rani Therapeutics Announces Strategic Program Prioritization, Expansion of Manufacturing and Plans to Streamline Business Operations to Support Near-Term Value Drivers and Long-Term Growth of the RaniPill® Technology Platform; Reports Preliminary Third Quarter 2023 Financial Results
10/25/23 The RaniPill® Capsule, Rani Therapeutics’ Oral Delivery Platform, was Well-Tolerated in 60-Day, Repeat-Administration, GLP Safety Study
10/19/23 Rani Therapeutics Announces Successful Oral Delivery of Monoclonal Antibody via High-Capacity Pill in Preclinical Study
10/12/23 Rani Therapeutics to Present Abstract on RT-102 at the 2023 Annual Meeting of the American Society for Bone and Mineral Research
10/03/23 Private companies invested in Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) copped the brunt of last week's US$18m market cap decline
09/18/23 Rani Therapeutics Initiates Phase 1 Study of RT-111 (RaniPill® Containing Ustekinumab Biosimilar, CT-P43)
RANI Chatroom

User Image Stu512 Posted - 04/30/24

$RANI Where did $8 go ???

User Image Capes Posted - 04/21/24

$OLB $DFLI $TALK $RANI $TRSG

User Image Stocks4thought Posted - 04/19/24

$RANI Looking to re-capture $1.35 today-- $11 in a few more days.

User Image Capes Posted - 04/19/24

$RANI

User Image Stocks4thought Posted - 04/19/24

$RANI $7 soon $ALT $LLY

User Image Stocks4thought Posted - 04/19/24

$RANI They will figure it out glp-1 agonist delivery vehicle- solve the needle thing and maybe less muscle atrophy........Looking for $10 NT..............you can see we were on her at $4. No bs promotion, discordless vacuum, website,,,,,,,,,,,,just make money.

User Image InvestInBratwurst Posted - 04/19/24

$RANI Opened a position here. 2500 shares at 6.

User Image bill85 Posted - 04/19/24

$RANI

User Image Stocks4thought Posted - 04/19/24

$RANI $6.40 will tag $6.7

User Image _www_larval_com_ Posted - 04/19/24

$RANI just soared 9% higher to 0% (~40Kv) a few minutes ago, 04/19 options, follow for more volatility.

User Image Stocks4thought Posted - 04/19/24

$RANI Should hit $7-----------------Holy Grail GLP-1 AG drugs- get past the needle thing- maybe muscle atrophy- too..............is it possible to prevent patent expiration on drugs with new delivery method? $ALT $LLY

User Image CallMeMyB Posted - 04/19/24

$RANI $BIOR the only logical explanation for huge drop in price is that the ranipill must have failed the clinical trials!

User Image _www_larval_com_ Posted - 04/18/24

$SMSI 7%[18%] $WISA -4%[-36%] $BPTH 3%[26%] $RANI -3%[-22%] most notable movement into the final minutes of trading.

User Image Stocks4thought Posted - 04/18/24

$RANI We said $8 and we meant it- back from vacation, girls gone wild list generating for tmrw..............Just profit takers today.

User Image naz2hi Posted - 04/18/24

$SMCI …in case anyone here is interested in other 𝗵𝗶𝗴𝗵𝗹𝘆 𝘀𝗽𝗲𝗰𝘂𝗹𝗮𝘁𝗶𝘃𝗲, yet at the same time possibly highly future rewarding stk picks. Well, here's one for you: Rani Therapeutics Holdings, Inc. ($RANI), developer of the so-call robotic pill (RaniPill) with enormous potential for penetration of several multi-billion injectable drug delivery mkts. Presently own a sizable position in it. Started adding shrs in the mid-$3s earlier this year. Present Mkt Cap is ~$394M but upside potential for if successful is enormous as it can disrupt several multi-billion-dollar mkts (even 1% penetration of these mkts is equitant to >$5B in rev.).

User Image JackDarwin Posted - 04/17/24

$RANI Nice Gap Up Formed With High Volume.

User Image _www_larval_com_ Posted - 04/17/24

$EDBL -8%[37%] $LGVN -5%[-41%] $SYTA 4%[19%] $RANI -4%[13%] $CUTR 3%[21%] most notable movement into the final minutes of trading.

User Image _www_larval_com_ Posted - 04/17/24

$RANI has reverted -9% lower to 9% (~888Kv) moments ago, 04/19 options, follow for more volatility.

User Image TICKERTUTOR Posted - 04/17/24

$RANI look at my post from Jan 31

User Image bill85 Posted - 04/17/24

$RANI Short Squeeze

User Image Stmkr Posted - 04/17/24

$RANI What is going on here?

User Image SqueezeFinder1 Posted - 04/17/24

Good morning all, $QQQ managed to hold that 430 level again as geopolitical tensions between Israel and Iraq have somewhat subsided, however the Fed may keep rates higher for longer to bring down inflation. I'm ready for a potential retest of 420 by 4/20 if we cannot convincingly hold 430. $PROK comes in strongly with 77% squeezability score supported by a strong daily curl on rising relative volume, low shares available, and not much resistance until $3.9 (juice target) and then $5. $BACK remains on top watch as it's retained its momentum for multiple sessions now. The squeeze score remains very high at 112% supported by low shares available, high short interest, microfloat and a beautiful daily chart. $RANI has continued to surge higher since Friday's initial watchlist add in the low $4's. The squeezability score is down to ~50% now as it's already produced a sizeable move despite sustaining high borrow rates. Let's keep it on watch for a potential move to double digits.

User Image seisdeplata Posted - 04/16/24

$RANI pills started ok for diabetes but insulin is cheap and users are cronic so injecting a needle is part of the way of life. Then pills could reach users with more serious problems. Osteoporosis, Inmuno Allergy, Inflamatory have good numbers but all framed in permitting phases. Then Obesity showed in the map. RANI is probably moving higher when users could be just people seeking weight loss in discreet dosages. The Pill works wonders in that dimension: dosage according to flexible users going for some kilos! They will not like the idea of injecting specially if the program is decided by diet plans in fractions. It could be far more then than 300 million obese users. Numbers Can be crazy. Talan seems to have caught up with a strategy for playing this….

User Image Fire_Monkey Posted - 04/16/24

$DXYZ $INVO $RANI $WISA $AMC 🔥🔥👀

User Image BowerTheBull Posted - 04/16/24

$BIOR $RANI was the right choice.

User Image Money_never_sleep Posted - 04/16/24

$RANI

User Image Fullratio Posted - 04/15/24

$RANI total assets is 78% more than its total liabilities: https://fullratio.com/stocks/nasdaq-rani/rani-therapeutics-holdings

User Image WagTwits Posted - 04/15/24

$RANI my stop loss triggered at 5.20 😭 today.. grrr

User Image Stocks4thought Posted - 04/15/24

$PROK LSD other trip tickets $INDPO $RANI $SLNO $VKTX

Analyst Ratings
Canaccord Genuity Buy Mar 27, 24
HC Wainwright & Co. Buy Mar 25, 24
Wedbush Outperform Feb 6, 24
HC Wainwright & Co. Buy Nov 9, 23
HC Wainwright & Co. Buy Sep 20, 23
HC Wainwright & Co. Buy Sep 8, 23
B of A Securities Buy Aug 21, 23
Wedbush Outperform Aug 17, 23
HC Wainwright & Co. Buy Aug 14, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Imran Talat Chief Executive Offi.. Chief Executive Officer Dec 06 Buy 2.27 10,000 22,700 484,455 12/07/23
Imran Talat Chief Executive Offi.. Chief Executive Officer Dec 04 Buy 2.57 5,000 12,850 474,455 12/06/23
Imran Talat Chief Executive Offi.. Chief Executive Officer Nov 29 Buy 2.05 20,000 41,000 469,455 12/01/23
Nanavaty Maulik Director Director Nov 16 Buy 1.98 500 990 500 11/20/23
South Cone Investments Limited... 10% Owner 10% Owner May 03 Buy 4.8118 2,040 9,816 6,856,714 05/05/23
South Cone Investments Limited... 10% Owner 10% Owner Apr 24 Buy 4.59 8,703 39,947 6,852,501 04/26/23
South Cone Investments Limited... 10% Owner 10% Owner Apr 20 Buy 5.13 5,950 30,524 6,843,798 04/24/23
South Cone Investments Limited... 10% Owner 10% Owner Apr 18 Buy 5.3724 1,850 9,939 6,837,848 04/20/23
South Cone Investments Limited... 10% Owner 10% Owner Apr 14 Buy 5.2704 1,901 10,019 6,835,998 04/18/23
South Cone Investments Limited... 10% Owner 10% Owner Apr 10 Buy 5.32 3,688 19,620 6,829,630 04/12/23
South Cone Investments Limited... 10% Owner 10% Owner Apr 04 Buy 5.49 11,696 64,211 6,818,391 04/06/23
South Cone Investments Limited... 10% Owner 10% Owner Mar 28 Buy 5.4937 3,510 19,283 6,790,127 03/30/23
South Cone Investments Limited... 10% Owner 10% Owner Mar 20 Buy 6.19 3,762 23,287 6,786,617 03/22/23
South Cone Investments Limited... 10% Owner 10% Owner Mar 16 Buy 6.13 4,305 26,390 6,782,855 03/20/23
South Cone Investments Limited... 10% Owner 10% Owner Mar 13 Buy 6.1391 2,463 15,121 6,778,550 03/15/23
South Cone Investments Limited... 10% Owner 10% Owner Feb 28 Buy 6.2986 711 4,478 6,765,655 03/02/23
South Cone Investments Limited... 10% Owner 10% Owner Feb 21 Buy 6.02 4,080 24,562 6,755,952 02/23/23
South Cone Investments Limited... 10% Owner 10% Owner Feb 14 Buy 5.23 19,250 100,678 6,733,904 02/16/23
South Cone Investments Limited... 10% Owner 10% Owner Dec 29 Buy 5.97 17,200 102,684 6,714,654 01/03/23
Quiroga Cortes Isidoro Alfonso 10% Owner 10% Owner Dec 30 Buy 6.0258 8,400 50,617 5,271,378 01/03/23
South Cone Investments Limited... 10% Owner 10% Owner Dec 16 Buy 7.6 13,300 101,080 6,688,297 12/20/22
South Cone Investments Limited... 10% Owner 10% Owner Dec 12 Buy 8.13 24,550 199,592 6,658,678 12/14/22
South Cone Investments Limited... 10% Owner 10% Owner Dec 08 Buy 7.97 24,540 195,584 6,634,128 12/12/22
South Cone Investments Limited... 10% Owner 10% Owner Dec 02 Buy 8.06 22,014 177,433 6,596,488 12/06/22
South Cone Investments Limited... 10% Owner 10% Owner Nov 30 Buy 7.96 8,202 65,288 6,574,474 12/02/22
South Cone Investments Limited... 10% Owner 10% Owner Nov 28 Buy 7.9536 3,720 29,587 6,566,272 11/30/22
South Cone Investments Limited... 10% Owner 10% Owner Nov 18 Buy 7.56 29,000 219,240 6,558,356 11/23/22
IMRAN MIR A Director Director Aug 17 Sell 11.07 80,252 888,390 66,445 08/19/22
Farquharson Andrew Director Director Aug 17 Sell 11.07 80,252 888,390 65,124 08/19/22